Cell Biotech Co., Ltd. (KOSDAQ:049960)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,930
0.00 (0.00%)
At close: May 30, 2025, 3:30 PM KST

Cell Biotech Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
18,1804,7577,8848,4589,8609,600
Upgrade
Short-Term Investments
62,64874,45056,51537,67118,67523,084
Upgrade
Trading Asset Securities
8,4648,2475,93319,23929,29922,203
Upgrade
Cash & Short-Term Investments
89,29287,45470,33265,36857,83454,887
Upgrade
Cash Growth
20.20%24.34%7.59%13.03%5.37%-7.32%
Upgrade
Accounts Receivable
4,1953,9914,5954,5664,6644,835
Upgrade
Other Receivables
1,149682.88943.86583.11268.43283.39
Upgrade
Receivables
5,6104,9765,7405,3305,2165,557
Upgrade
Inventory
4,7024,2034,1224,1023,5893,503
Upgrade
Prepaid Expenses
134.46287.27691.85500.5292.5218.67
Upgrade
Other Current Assets
320.08228.191,044354.58587.81746.72
Upgrade
Total Current Assets
100,05897,14881,92975,65567,51964,913
Upgrade
Property, Plant & Equipment
29,77530,46332,93733,63834,05736,602
Upgrade
Long-Term Investments
501.94501.94501.943,7868,4272
Upgrade
Other Intangible Assets
1,5761,6061,5991,7931,5361,802
Upgrade
Long-Term Accounts Receivable
000000
Upgrade
Long-Term Deferred Tax Assets
216.96216.96182.29449.3751.561,395
Upgrade
Other Long-Term Assets
428.69461.66491.37517.21585.15587.54
Upgrade
Total Assets
132,557130,398117,641115,839112,877105,301
Upgrade
Accounts Payable
566.54680.27578.391,3701,224887.65
Upgrade
Accrued Expenses
606.21481.51489.15443.91470.95496.32
Upgrade
Current Portion of Leases
612.71650.28621.14600.78402.89658.65
Upgrade
Current Income Taxes Payable
1,6881,404-1,038814.73-
Upgrade
Current Unearned Revenue
24.2227.5727.0330.950.4441.52
Upgrade
Other Current Liabilities
5,5342,6193,1063,9052,8022,546
Upgrade
Total Current Liabilities
9,0315,8634,8217,3895,7664,630
Upgrade
Long-Term Leases
246.64366.66934.17357.79423.49686.44
Upgrade
Other Long-Term Liabilities
----0-
Upgrade
Total Liabilities
9,2786,2295,7557,7476,1895,317
Upgrade
Common Stock
4,7004,7004,7004,7004,7004,700
Upgrade
Additional Paid-In Capital
12,76012,76012,76012,76012,76012,760
Upgrade
Retained Earnings
129,254130,264118,217114,993109,894102,696
Upgrade
Treasury Stock
-23,978-23,978-23,978-23,978-20,258-20,258
Upgrade
Comprehensive Income & Other
542.82422.69186.4-382.91-408.4286.97
Upgrade
Shareholders' Equity
123,279124,168111,885108,092106,68799,985
Upgrade
Total Liabilities & Equity
132,557130,398117,641115,839112,877105,301
Upgrade
Total Debt
859.341,0171,555958.57826.381,345
Upgrade
Net Cash (Debt)
88,43286,43768,77764,40957,00753,542
Upgrade
Net Cash Growth
21.43%25.68%6.78%12.98%6.47%-8.16%
Upgrade
Net Cash Per Share
12913.4812629.7410049.379342.068061.437547.42
Upgrade
Filing Date Shares Outstanding
6.846.846.846.847.077.07
Upgrade
Total Common Shares Outstanding
6.846.846.846.847.077.09
Upgrade
Working Capital
91,02691,28677,10868,26661,75460,283
Upgrade
Book Value Per Share
18012.9218142.9416348.1715793.9115086.6814094.07
Upgrade
Tangible Book Value
121,702122,563110,286106,299105,15198,183
Upgrade
Tangible Book Value Per Share
17782.5717908.3116114.5315531.8814869.4913840.05
Upgrade
Land
9,6969,6969,7659,7659,7659,784
Upgrade
Buildings
20,12319,67519,53713,34913,85414,389
Upgrade
Machinery
25,81325,84725,6447,2288,0339,682
Upgrade
Construction In Progress
67.25385.42338.95993.9247.2695
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.